Maarten Hoek

Who is Maarten Hoek?

Maarten Hoek is the Senior Vice President, Head of Research at Maze Therapeutics, a clinical-stage company developing small molecule precision medicines for common diseases.1234 He has held this position since March 2022.13

Professional Experience

Prior to his current role, Hoek held several positions at Maze Therapeutics and other companies1:

• Senior Director at Maze Therapeutics (February 2019 - March 2022)
• Senior Director at Third Rock Ventures (May 2018 - February 2019)
• Director and Principal Scientist at Merck (February 2017 - May 2018)
• Associate Principal Scientist at Merck (July 2012 - June 2015)
• Senior Research Biologist at Merck (May 2007 - May 2009)
• Postdoctoral Fellow at Cold Spring Harbor Laboratory (May 2000 - June 2007)
• Research Assistant at Rockefeller University (July 1992 - July 1994)

Education

• Ph.D. in Biological and Biomedical Sciences from Rockefeller University (1994-2001)
• B.A. in Biology from Swarthmore College (1988-1992)

Key Contributions

• Helped drive Maze Therapeutics from stealth-mode to launch by contributing to the integrated human genetics and functional genomics platform and initiating drug discovery on lead programs1
• Drove operational implementation of biology and early hit-finding activities by building an external capability network1
• Contributed to the development of Maze's APOL1 inhibitor and other novel precision medicines for kidney disease5